Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.27 USD | -0.23% | -2.51% | -14.77% |
30/05 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
16/05 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.77% | 18Cr | |
+51.85% | 5.79TCr | |
+41.42% | 4.03TCr | |
-5.25% | 3.99TCr | |
-5.16% | 2.85TCr | |
+12.79% | 2.64TCr | |
-20.18% | 1.93TCr | |
+30.88% | 1.24TCr | |
+0.61% | 1.22TCr | |
+25.06% | 1.22TCr |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Transcript : Abeona Therapeutics Inc., 2022 Earnings Call, Mar 29, 2023